Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2010
08/05/2010US20100196933 Recombinant Polypeptides for Diagnosing Infection with Trypanosoma Cruzi
08/05/2010US20100196919 Peptides, antibodies and fragments thereof for the treatment and diagnostic of celiac disease
08/05/2010US20100196918 Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity
08/05/2010US20100196916 Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
08/05/2010US20100196915 Method of Detecting Oncogenesis of Hematopoietic Cells
08/05/2010US20100196913 Mutant AOX1 Promoters
08/05/2010US20100196909 Parp-based cytochemical and histochemical detection methods and kits therefore
08/05/2010US20100196891 IBC-1 (Invasive Breast Cancer-1), a Putative Oncogene Amplified in Breast Cancer
08/05/2010US20100196582 Soybeans with reduced isoflavones
08/05/2010US20100196580 Fad-2 mutants and high oleic acid plants
08/05/2010US20100196579 Phosphatidic acid phosphatase homologs and use thereof
08/05/2010US20100196524 Novel peptides and methods for producing them
08/05/2010US20100196458 Modified cytokines for use in cancer therapy
08/05/2010US20100196421 clostridial neurotoxin propeptide which has a light chain region, a heavy chain region, where the light and heavy chain regions are linked by a disulfide bond, and an intermediate region connecting the light and heavy chain regions; intermediate region has a highly specific protease cleavage site
08/05/2010US20100196420 Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
08/05/2010US20100196419 Enhancement of glycoprotein incorporation into virus-like particles
08/05/2010US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS
08/05/2010US20100196410 Streptococcus pneumoniae Antigens and Vaccines
08/05/2010US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof
08/05/2010US20100196407 Tick galectin
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196397 Five-helix protein
08/05/2010US20100196395 Anti-igf antibodies
08/05/2010US20100196393 Modulation of blood brain barrier protein expression
08/05/2010US20100196392 Anti-system asc amino acid transporter 2 (asct2) antibody
08/05/2010US20100196390 Agonist anti-trkb monoclonal antibodies
08/05/2010US20100196383 Connective Tissue Growth Factor (CTGF-3)
08/05/2010US20100196382 Nontypeable Haemophilus Influenzae Virulence Factors
08/05/2010US20100196381 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
08/05/2010US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo
08/05/2010US20100196377 Methods of treating, diagnosing or detecting cancer
08/05/2010US20100196375 Engineered scFv against Bovine Herpes Virus Type I
08/05/2010US20100196372 FcgammaRIIB Fusion Proteins and Compositions Thereof
08/05/2010US20100196370 Fusion protein of immunoglobulin fc and human apolipoprotein(a) kringle fragment
08/05/2010US20100196356 Tumour Growth Inhibitory Compounds and Methods of their Use
08/05/2010US20100196350 Pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma
08/05/2010US20100196349 Reeler domain containing protein
08/05/2010US20100196345 Production of high mannose proteins in plant culture
08/05/2010US20100196336 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
08/05/2010US20100196335 Methods and Compositions for Regulated Expressions of Nucleic Acid at Post-Transcriptional Level
08/05/2010US20100196326 Method and system for biasing cellular development
08/05/2010US20100196315 IL-12/p40 BINDING PROTEINS
08/05/2010US20100196309 Interleukin-21 variants with altered binding to the il-21 receptor
08/05/2010US20100196265 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
08/05/2010US20100193355 Novel glucose dehydrogenase and method for producing the dehydrogenase
08/05/2010US20100192985 Compositions and methods comprising serine protease variants
08/05/2010DE102009008252A1 Autokatalytischer Proteinlinker und seine Verwendung zur Herstellung von Fusionsproteinen Autocatalytic protein linker and its use for the production of fusion proteins
08/05/2010DE102009007272A1 New nucleic acid sequence, which encodes a polypeptide with alcohol dehydrogenase activity, comprising e.g. nucleic acid sequence that hybridizes under stringent conditions with specific nucleic acid sequence, useful to produce polypeptide
08/05/2010CA2788452A1 Method of making dna tag
08/05/2010CA2751268A1 Nucleic acid delivery using modified chitosans
08/05/2010CA2751266A1 Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders
08/05/2010CA2751223A1 Novel cell lines and methods
08/05/2010CA2751215A1 Cell lines expressing cftr and methods of using them
08/05/2010CA2751213A1 Methods of detecting sepsis
08/05/2010CA2751159A1 Cell lines expressing nav and methods of using them
08/05/2010CA2751036A1 Method for producing carotenoids from paracoccus bacteria
08/05/2010CA2750983A1 Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
08/05/2010CA2750879A1 Adaptors for nucleic acid constructs in transmembrane sequencing
08/05/2010CA2750874A1 Hybridization linkers
08/05/2010CA2750770A1 Non-ad5 adenoviral vectors and methods and uses related thereto
08/05/2010CA2750576A1 Novel peptides and methods for producing them
08/05/2010CA2750499A1 Novel synthetic agonists of tlr9
08/05/2010CA2750456A1 Transgenic plants having altered nitrogen metabolism
08/05/2010CA2750338A1 Sequence-specific large volume sample preparation method and assay
08/05/2010CA2750245A1 Polynucleotide aptamer-based cross-linked materials and uses thereof
08/05/2010CA2750007A1 Plants having enhanced yield-related traits and a method for making the same
08/05/2010CA2749966A1 Il-1 binding proteins
08/05/2010CA2749708A1 Engineering nf-yb transcription factors for enhanced drought resistance and increased yield in transgenic plants
08/05/2010CA2749325A1 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
08/05/2010CA2748500A1 Measuring g protein coupled receptor activation
08/05/2010CA2748228A1 Selection of animals for desired milk and/or tissue profile
08/04/2010EP2214018A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
08/04/2010EP2213752A1 Recombinant Newcastle disease virus RNA expression systems and vaccines
08/04/2010EP2213751A1 Polymer for detection of target substance, and method for detection of target substance
08/04/2010EP2213747A1 Method for producing membrane protein
08/04/2010EP2213746A1 Cell for use in the production of exogenous protein, and production process using the cell
08/04/2010EP2213745A1 Improved bacillus host cell
08/04/2010EP2213744A1 Minicircle vector production
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213742A1 Chimeric antigens for breaking host tolerance to foreign antigens
08/04/2010EP2213741A2 Compositions and methods of using a synthetic DNAse I
08/04/2010EP2213740A1 Human telomerase catalytic subunit
08/04/2010EP2213739A1 Flavonoid glucosyltransferase and use of same
08/04/2010EP2213738A2 siRNA molecules targeting Bcl-2
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213736A2 Method for inhibiting the expression of a target gene and medicine for treating a tumour illness
08/04/2010EP2213735A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same
08/04/2010EP2213734A1 Candida utilis containing gamma-glutamylcysteine
08/04/2010EP2213731A1 Variant foki cleavage half-domains
08/04/2010EP2213730A1 Primary cultured adipocytes for gene therapy
08/04/2010EP2213683A1 Variant Fc regions
08/04/2010EP2213309A1 Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent
08/04/2010EP2213302A2 DR4 antibodies and uses thereof
08/04/2010EP2213300A1 Composition and method for treating cancer using herpes virus
08/04/2010EP2213296A1 Medicinal composition containing highly functionalized chimeric protein
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/04/2010EP2213291A1 Antisense inhibition of PTP1B expression
08/04/2010EP2212435A1 Fused gene(s)
08/04/2010EP2212425A2 Improvement of transfection results of non-viral gene delivery systems by influencing the congenital immune system
08/04/2010EP2212423A2 Poxviral oncolytic vectors
1 ... 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 ... 4023